
即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.

CAS号 | 1369773-39-6 | 货号 | BCP11897 |
中文名 | 沙库比曲钙盐 | ||
英文名 | Sacubitril hemicalcium salt | ||
中文别名 | |||
英文别名 | LCZ696 hemicalcium salt; LCZ 696 hemicalcium salt; LCZ696 hemicalcium salt;AHU-377 hemicalcium salt;AHU377 hemicalcium salt;AHU 377 hemicalcium salt; | ||
SMILES | CCOC(=O)C(C)CC(CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)[O-].CCOC(=O)C(C)CC(CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)[O-].[Ca+2] | ||
化学名称 | |||
分子式 | 2(C24H28NO5).Ca | 分子量 | 861.04 |
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | LCZ696 is a novel single molecule comprising molecular moieties of valsartan and NEP inhibitor prodrug AHU377 (1:1 ratio). Oral administration of LCZ696 caused dose-dependent increases in atrial natriuretic peptide immunoreactivity (due to NEP inhibition) in Sprague-Dawley rats and provided sustained, dose-dependent blood pressure reductions in hypertensive double-transgenic rats. In healthy participants, a randomized, double-blind, placebo-controlled study (n = 80) of single-dose (200-1200 mg) and multiple-dose (50-900 mg once daily for 14 days) oral administration of LCZ696 showed that peak plasma concentrations were reached rapidly for valsartan (1.6-4.9 hours), AHU377 (0.5-1.1 hours), and its active moiety, LBQ657 (1.8-3.5 hours). LCZ696 is superior to valsartan alone in reducing blood pressure. Preliminary results from a Phase II trial showed that LCZ696 reduced NT-proBNP to a greater extent than valsartan alone, and in addition LCZ696 had beneficial effects on symptoms. |
相关产品推荐
查看更多 >Tags:Sacubitril hemicalcium salt 供应商,Sacubitril hemicalcium salt 购买,Sacubitril hemicalcium salt 生产,Sacubitril hemicalcium salt 批量,Sacubitril hemicalcium salt 供应,Sacubitril hemicalcium salt 订购,Sacubitril hemicalcium salt 采购